Bita Fakhri, MD, MPH

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address521 Parnassus Avenue
San Francisco CA 94117
Phone--
ORCID ORCID Icon0000-0002-2124-7243 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Washington University School of Medicine, St. Louis, MOFellowship2018Hematolgoy and Medical Oncology
    Boston University Medical Center, Boston, MAResidency2015Internal Medicine
    Washington University School of Medicine, St. Louis, MOGraduate Certificate in Clinical Investigation2018Clinical Investigation
    Yale School of Public Health, New Haven, CTMPH2011Epidemiology and Biostatistics
    Iran University of Medical Sciences, Tehran, IranMD2009Medicine
    University of California, San Francisco, CA2021Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Helen Diller Family Comprehensive Cancer Center2020  - 2021Junior Faculty Development Award
    UCSF2021Division of Hematology and Oncology Annual Teaching Award

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021. J Natl Compr Canc Netw. 2021 11; 19(11):1218-1230. Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H. PMID: 34781267.
      View in: PubMed   Mentions:
    2. Current and emerging treatment options in primary mediastinal B-cell lymphoma. Ther Adv Hematol. 2021; 12:20406207211048959. Fakhri B, Ai W. PMID: 34659697; PMCID: PMC8511915.
      View in: PubMed   Mentions:
    3. Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome. Leuk Lymphoma. 2021 11; 62(11):2600-2611. Banerjee R, Fakhri B, Shah N. PMID: 34151714.
      View in: PubMed   Mentions:    Fields:    
    4. Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma. Leuk Lymphoma. 2021 10; 62(10):2408-2415. Fakhri B, Yilmaz E, Gao F, Ambinder RF, Jones R, Bartlett NL, Cashen A, Wagner-Johnston N. PMID: 33988071.
      View in: PubMed   Mentions:    Fields:    
    5. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet. 2021 03 06; 397(10277):892-901. Mato AR, Shah NN, Jurczak W, Cheah CY, Pagel JM, Woyach JA, Fakhri B, Eyre TA, Lamanna N, Patel MR, Alencar A, Lech-Maranda E, Wierda WG, Coombs CC, Gerson JN, Ghia P, Le Gouill S, Lewis DJ, Sundaram S, Cohen JB, Flinn IW, Tam CS, Barve MA, Kuss B, Taylor J, Abdel-Wahab O, Schuster SJ, Palomba ML, Lewis KL, Roeker LE, Davids MS, Tan XN, Fenske TS, Wallin J, Tsai DE, Ku NC, Zhu E, Chen J, Yin M, Nair B, Ebata K, Marella N, Brown JR, Wang M. PMID: 33676628.
      View in: PubMed   Mentions: 7     Fields:    
    6. A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e583-e587. Kennedy VE, Ruiz-Cordero R, Jangam D, Wen KW, Dunavin N, Ohgami RS, Bhargava P, Ai W, Fakhri B. PMID: 33814335.
      View in: PubMed   Mentions:    Fields:    
    7. The role of acalabrutinib in adults with chronic lymphocytic leukemia. Ther Adv Hematol. 2021; 12:2040620721990553. Fakhri B, Andreadis C. PMID: 33613932; PMCID: PMC7871059.
      View in: PubMed   Mentions: 2  
    8. Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. Clin Lymphoma Myeloma Leuk. 2021 03; 21(3):139-146. Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB. PMID: 33478921.
      View in: PubMed   Mentions:    Fields:    
    9. Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. Leuk Lymphoma. 2021 04; 62(4):1003-1006. Parks AL, Kambhampati S, Fakhri B, Andreadis C, Gray L, Wong SW, Shah N, Fang MC. PMID: 33258699; PMCID: PMC8012226.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2021 04; 21(4):246-256.e2. Kambhampati S, Hunter B, Varnavski A, Fakhri B, Kaplan L, Ai WZ, Pampaloni M, Huang CY, Martin T, Damon L, Andreadis CB. PMID: 33288485.
      View in: PubMed   Mentions:    Fields:    
    11. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide. Ann Diagn Pathol. 2020 Jun; 46:151534. Wen KW, Fakhri B, Menke J, Ruiz-Cordero R, Gill RM, Ohgami RS. PMID: 32473554.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy. Clin Cancer Res. 2020 07 15; 26(14):3589-3596. Mato AR, Roeker LE, Jacobs R, Hill BT, Lamanna N, Brander D, Shadman M, Ujjani CS, Yazdy MS, Perini GF, Pinilla-Ibarz JA, Barrientos J, Skarbnik AP, Torka P, Pu JJ, Pagel JM, Gohil S, Fakhri B, Choi M, Coombs CC, Rhodes J, Barr PM, Portell CA, Parry H, Garcia CA, Whitaker KJ, Winter AM, Sitlinger A, Khajavian S, Grajales-Cruz AF, Isaac KM, Shah P, Akhtar OS, Pocock R, Lam K, Voorhees TJ, Schuster SJ, Rodgers TD, Fox CP, Martinez-Calle N, Munir T, Bhavsar EB, Bailey N, Lee JC, Weissbrot HB, Nabhan C, Goodfriend JM, King AC, Zelenetz AD, Dorsey C, Bigelow K, Cheson BD, Allan JN, Eyre TA. PMID: 32198151; PMCID: PMC8588795.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    13. Immune-related Adverse Events Associated With Checkpoint Inhibition in the Setting of CAR T Cell Therapy: A Case Series. Clin Lymphoma Myeloma Leuk. 2020 03; 20(3):e118-e123. Kambhampati S, Gray L, Fakhri B, Lo M, Vu K, Arora S, Kaplan L, Ai WZ, Andreadis C. PMID: 31948859.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL. Oncology (Williston Park). 2019 Nov 14; 33(11). Fakhri B, Andreadis C. PMID: 31769861.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database. Cancer. 2020 02 15; 126(4):808-813. Fakhri B, Fiala MA, Shah N, Vij R, Wildes TM. PMID: 31721140; PMCID: PMC6992490.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    16. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer. 2020 01 15; 126(2):293-303. Ayers EC, Li S, Medeiros LJ, Bond DA, Maddocks KJ, Torka P, Mier Hicks A, Curry M, Wagner-Johnston ND, Karmali R, Behdad A, Fakhri B, Kahl BS, Churnetski MC, Cohen JB, Reddy NM, Modi D, Ramchandren R, Howlett C, Leslie LA, Cytryn S, Diefenbach CS, Faramand R, Chavez JC, Olszewski AJ, Liu Y, Barta SK, Mukhija D, Hill BT, Ma H, Amengual JE, Nathan S, Assouline SE, Orellana-Noia VM, Portell CA, Chandar A, David KA, Giri A, Hess BT, Landsburg DJ. PMID: 31568564.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):e532-e535. Fakhri B, Cashen AF, Duncavage EJ, Watkins MP, Wartman LD, Bartlett NL. PMID: 31279773.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    18. Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma. Br J Haematol. 2019 02; 184(4):524-535. Hill BT, Nastoupil L, Winter AM, Becnel MR, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Fakhri B, Reddy P, Smith SD, Mukhija D, Jagadeesh D, Desai A, Alderuccio JP, Lossos IS, Mehra P, Portell CA, Goldman ML, Calzada O, Cohen JB, Hussain MJ, Ghosh N, Caimi P, Tiutan T, Martin P, Kodali A, Evens AM, Kahl BS. PMID: 30575016; PMCID: PMC6486816.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    19. Bones in Multiple Myeloma: Imaging and Therapy. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:638-646. Zamagni E, Cavo M, Fakhri B, Vij R, Roodman D. PMID: 30231385.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):219-224. Fakhri B, Fiala MA, Tuchman SA, Wildes TM. PMID: 29429818; PMCID: PMC5837946.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Current and emerging treatment options for mantle cell lymphoma. Ther Adv Hematol. 2017 Aug; 8(8):223-234. Fakhri B, Kahl B. PMID: 28811872; PMCID: PMC5544150.
      View in: PubMed   Mentions: 8  
    22. Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature. J Gastrointest Oncol. 2017 Jun; 8(3):379-386. Fakhri B, Lim KH. PMID: 28736626; PMCID: PMC5506283.
      View in: PubMed   Mentions: 7  
    23. Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML. Case Rep Hematol. 2017; 2017:3728429. Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A. PMID: 28316846; PMCID: PMC5337855.
      View in: PubMed   Mentions:
    24. Clonal Evolution in Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2016 08; 16 Suppl:S130-4. Fakhri B, Vij R. PMID: 27521309.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Halfway there: the past, present and future of haploidentical transplantation. Bone Marrow Transplant. 2017 Jan; 52(1):1-6. Slade M, Fakhri B, Savani BN, Romee R. PMID: 27454072.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    Bita's Networks
    Concepts (113)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (19)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California